Filing Details
- Accession Number:
- 0000899243-19-029406
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-17 16:16:16
- Reporting Period:
- 2019-12-13
- Accepted Time:
- 2019-12-17 16:16:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1604950 | Scpharmaceuticals Inc. | SCPH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1303480 | H John Tucker | C/O Scpharmaceuticals Inc. 2400 District Avenue, Suite 310 Burlington MA 01803 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-12-13 | 5,000 | $5.24 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $5.17 to $5.2335, inclusive. The reporting person undertakes to provide to scPharmaceuticals Inc., any security holder of scPharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
